A Prospective Cohort Study to Assess Clinical Effectiveness of an Investigational Digital Therapeutic (CT-155) in Patients With Experiential Negative Symptoms of Schizophrenia
Clinical trial NCT06791122 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06791122
- Sponsor
- Boehringer Ingelheim
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-23
- Primary completion
- 2026-08-26
- Enrollment
- 262
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.